BACKGROUND
Depression and anxiety are common among patients with multiple sclerosis (MS) and are frequently present at the time of MS diagnosis.
METHODS
POSIDONIA was a 12-month, observational, prospective study conducted in Italy to evaluate the impact of disease-modifying treatment (DMT) on